Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhoo...
Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group
About this item
Full title
Author / Creator
Biondi, A , Valsecchi, MG , Seriu, T , D'Aniello, E , Willemse, MJ , Fasching, K , Pannunzio, A , Gadner, H , Schrappe, M , Kamps, WA , Bartram, CR , van Dongen, JJM and Panzer-Grümayer, ER
Publisher
London: Nature Publishing
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing
Subjects
More information
Scope and Contents
Contents
The medium-risk B cell precursor acute lymphoblastic leukemia (ALL) accounts for 50-60% of total childhood ALL and comprises the largest number of relapses still unpredictable with diagnostic criteria. To evaluate the prognostic impact of minimal residual disease (MRD) in this specific group, a case control study was performed in patients classifie...
Alternative Titles
Full title
Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_72402536
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_72402536
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/sj.leu.2401922
